CRISPR/Cas9 Control
Accelerate genome editing experiments with MBP’s high-precision CRISPR/Cas9 control vectors.
MBP’s CRISPR-Cas9 control vectors are designed for accurate and controlled delivery of CRISPR components in mammalian cells. These controls allow researchers to optimize transduction conditions, establish stable experimental baselines, and evaluate gene editing efficiency for genetic engineering studies. They are precision-designed for stable expression and high functionality, and support a diverse range of applications, including gene knockout validation, therapeutic research modeling, pathway analysis, and functional genomics.
What you will find:
- SpCas9 sgRNA AAV viruses control (serotypes 1–11) for Streptococcus pyogenes Cas9 experiments.
- SaCas9 Scrambled sgRNA viruses control for the smaller Staphylococcus aureus Cas9 nuclease.
- All-in-One AAV Control Vectors contain both a non-targeting scrambled sgRNA and saCas9
- Non-Viral CRISPR Control Plasmids used in transient transfection studies for scrambled sgRNA expression
- Ampicillin-Resistant AAV Backbones for stable cloning and propagation.
- Serotype-Specific All-in-One Virions as a negative control for tissue-specific assessment
MBP CRISPR/Cas9 controls provide reliable tools for optimizing workflows and validating standardized genome editing. These control systems are extensively used in translational gene therapy development, neuroscience, molecular biology studies, and cancer research, and allow streamlined on-target activity analysis and improve overall system efficiency.
Contact the expert team at MBP to get high-quality CRISPR control for your next successful experiment.
